Millet Products Study - Investigation of Glycemic Index and Satiety
NCT ID: NCT02075788
Last Updated: 2016-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2014-01-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determination of Glycaemic Index and Insulinaemic Index Values of 6 Food Products in 3 Separate Research Centers
NCT01870570
Millet-based Muffins, Glycaemic Response, Insulinemic Response and Gastric Emptying
NCT04599738
Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products
NCT02650674
Impact of Partially Replacing Wheat With Millets or Bengal Gram Flour in Rotis on Glycemia and Prediabetes Reversal
NCT07205705
Effect of Fiber Composite-enriched Breads on Glycemic Responses
NCT03224806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This project will examine the effect of millet, on glycemic response and satiety. To determine the effect of product matrix and processing methods, testing will be done using an extruded snack, porridge, a couscous-like product and a biscuit.
All product servings will provide 50 g of available carbohydrate and will be consumed by participants within 10 minutes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Commercial white bread
All product servings will provide 50 g of available carbohydrate and will be consumed by participants within 10 minutes.
Commercial white bread
Millet based products (porridge etc.)
All product servings will provide 50 g of available carbohydrate and will be consumed by participants within 10 minutes.
Millet based products (porridge etc.)
Corn based products (porridge etc.)
All product servings will provide 50 g of available carbohydrate and will be consumed by participants within 10 minutes.
Corn based products (porridge etc.)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Commercial white bread
Corn based products (porridge etc.)
Millet based products (porridge etc.)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal fasting plasma glucose (\<5.6 mmol/L but not below 3.6 mmol/L)
* Normal glucose tolerance (evaluated by a 75 g oral glucose test, i.e. \<7.8 mmol/L but not below 3.6 mmol/L)
* BMI ranging from 18.5 to 29.9 kg/m2
Exclusion Criteria
* Regular consumption of millet as defined by questionnaire at screening defined as more than 1x per week
* Smoking or use of recreational drugs
* Heavy alcohol use (defined as typically \>14 drinks per week or \>4 drinks on one occasion)
* Very low fibre consumption as assessed by 24 hour food diary and self-reported fruit/vegetable/whole grain servings.
* Restrained eater as defined by the questionnaire at screening (Three Factor Eating Questionnaire, Stunkard et al.,1985)
* Food neophobic defined by Food Neophobia Scale questionnaire
* Unusual sleep patterns or irregular breakfast consumption
* Recent (i.e. \>4 kg in previous 3 months) or intended weight loss or gain
* Food allergies or any life-threatening allergy (food or otherwise)
* Inflammatory bowel disease or other gastrointestinal disorders
* Use of drugs which influence carbohydrate metabolism
* Training or elite athletes
* Inability to adhere to Study Protocols
19 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bunge Global Innovation Incorporated
UNKNOWN
University of Guelph
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amanda Wright, Ph.D.
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Nutraceutical Research Unit, University of Guelph
Guelph, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13AP004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.